Support to the evaluation of the Drug Precursors Regulations (Regulation (EC) No 273/2004 of the European Parliament and of the Council of 11.2.2004 on drug precursors and Council Regulation (EC) No 111/2005 of 22.12.2004 laying down rules for the monitoring of trade between the Community and third countries in drug precursors) | Tenderlake

Support to the evaluation of the Drug Precursors Regulations (Regulation (EC) No 273/2004 of the European Parliament and of the Council of 11.2.2004 on drug precursors and Council Regulation (EC) No 111/2005 of 22.12.2004 laying down rules for the monitoring of trade between the Community and third countries in drug precursors)

Contract Value:
EUR 210K - 210K
Notice Type:
Contract Notice
Published Date:
12 August 2017
Closing Date:
25 September 2017
Location(s):
BE1 RÉGION DE BRUXELLES-CAPITALE/BRUSSELS HOOFDSTEDELIJK GEWEST (BE Belgium/BELGIQUE-BELGIË)
Description:

The objective of the study is to provide the European Commission with the necessary information and analysis in support of the evaluation of the 2 EU Regulations on Drug Precursors (Regulation (EC) No 273/2004 of the European Parliament and of the Council and Council Regulation (EC) No 111/2005). The study results will be used in the preparation of the report on the implementation and functioning of the Regulations on drug precursors, which the Commission must submit by 31.12.2019 to the European Parliament and to the Council. In order to fulfil its objective, the study requires the following tasks to be carried out, in line with the Better Regulation principles:

1. establishment of the evaluation methodology; 2. providing information on the implementation and assessing the effectiveness, efficiency, coherence, relevance and EU added value of the Regulations; 3. assessing the need for additional action to monitor and control suspicious transactions with non-scheduled substances; 4. stakeholders consultation and open public consultation; 5. validation workshop.



Service contract for a study. The objective is to provide the European Commission with the necessary information and analysis in support of the evaluation of the 2 EU Regulations on Drug Precursors (Regulation (EC) No 273/2004 of the European Parliament and of the Council and Council Regulation (EC) No 111/2005). The study results will be used in the preparation of the report on the implementation and functioning of the Regulations on drug precursors, which the Commission must submit by 31.12.2019 to the European Parliament and to the Council. In order to fulfil its objective, the study requires the following tasks to be carried out, in line with the Better Regulation principles:

task 1 — establishment of the evaluation methodology; task 2 — providing information on the implementation and assessing the effectiveness, efficiency, coherence, relevance and EU added value of the Regulations; task 3 — assessing the need for additional action to monitor and control suspicious transactions with non-scheduled substances; task 4 — stakeholders consultation and open public consultation; task 5 — validation workshop.

Download full details as .pdf
The Buyer:
Directorate-General for Internal Market, Industry, Entrepreneurship and SMEs, Directorate D: Consumer, Environmental and Health Technologies
CPV Code(s):
79400000 - Business and management consultancy and related services
79410000 - Business and management consultancy services